Company intelligence / Profile preview

early VC

Berlin, Berlin, Germany

Ownership: Private
Employees: ~80
Development stage: Other

Overview

Earlybird Venture Capital is a prominent European venture capital firm that invests in all development and growth phases of technology companies. The firm operates a dedicated Health Fund that focuses on digital health, medical devices, diagnostics, enabling technologies, and biopharma across Europe and the United States. Earlybird provides not only financial resources but also strategic support and access to an international network to help its portfolio companies scale globally. With over €2 billion under management, it is one of the most established and successful venture capital firms in the European ecosystem.

Industry: Investors

Beyond the preview

Go deeper on early VC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on early VC.

Explore the full profile